FGP
PTEN icon

Freestone Grove Partners’s Patterson-UTI PTEN Stock Holding History

Freestone Grove Partners’s Portfolio PTEN Stock Details PTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8M Buy
1,607,903
+1,222,978
+318% +$13.6M 0.09% 245
2026
Q1 		$4.17M Buy
+384,925
New +$3.3M 0.03% 335
2025
Q1 		– Sell
-1,743,758
Closed -$14.4M – 750
2024
Q4 		$14.4M Buy
+1,743,758
New +$14M 0.18% 170

Other funds holding PTEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Freestone Grove Partners's PTEN Position: Q2 2026 in Review

Freestone Grove Partners increased its Patterson-UTI (PTEN) stake by 318% in Q2 2026, buying an estimated $13.6M and bringing the position to 1,607,903 shares worth $14.8M. The position accounts for 0.09% of the portfolio, ranked #245.

Freestone Grove Partners first reported a position in PTEN in Q4 2024 and has held it in 3 quarters since. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Freestone Grove Partners held 1,607,903 shares of Patterson-UTI worth $14.8M as of Q2 2026.
  • Freestone Grove Partners bought 1,222,978 Patterson-UTI shares in Q2 2026, an estimated $13.6M.
  • Patterson-UTI made up 0.09% of Freestone Grove Partners's portfolio in Q2 2026, its #245 holding.
  • Freestone Grove Partners first reported a position in Patterson-UTI in Q4 2024 and has held it in 3 quarters since.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.